How should I discuss with my clinician at my upcoming appointment that I've been taking sertraline 50 mg daily for four years, have chronic cold sensation, and want a gradual taper with appropriate laboratory evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Discuss Sertraline Tapering at Your Appointment

You should clearly communicate to your clinician that you want to discontinue sertraline 50 mg after four years of use, request a gradual taper starting with a 5-10% dose reduction every 2-4 weeks, and ask for baseline laboratory evaluation including a comprehensive metabolic panel to assess your chronic cold sensation before beginning the taper.

Key Points to Communicate

Your Current Situation

  • Duration and dose: You've been taking sertraline 50 mg daily for four years
  • Symptom concern: You're experiencing chronic cold sensation that may be medication-related
  • Your goal: You want to safely discontinue the medication with appropriate medical monitoring

Specific Taper Request

Request a gradual, individualized tapering schedule that follows evidence-based protocols. While the available guidelines focus on benzodiazepine tapering 1, the principles of gradual dose reduction apply to sertraline discontinuation as well. The FDA label for sertraline explicitly states: "A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible" 2.

For sertraline specifically:

  • Initial reduction: Start with a 5-10% dose reduction from your current 50 mg dose
  • Timing: Wait 2-4 weeks between dose reductions to assess your response 3
  • Monitoring: Schedule follow-up appointments every 2-4 weeks during the taper to evaluate for withdrawal symptoms

Laboratory Evaluation to Request

Ask for baseline blood work before starting the taper, specifically:

  • Comprehensive metabolic panel (sodium, potassium, chloride, glucose, CO2, BUN, creatinine) - to evaluate your cold sensation and establish baseline values 4
  • Thyroid function tests (TSH, free T4) - cold intolerance can indicate thyroid dysfunction
  • Complete blood count - to rule out anemia as a cause of cold sensation

The evidence shows sertraline does not typically cause significant changes in routine chemistry values 4, but baseline testing is prudent given your symptom and the duration of treatment.

Withdrawal Symptoms to Discuss

Be prepared to discuss potential discontinuation symptoms with your clinician 2, 3:

Somatic symptoms may include:

  • Dizziness and light-headedness
  • Nausea and gastrointestinal upset
  • Fatigue, lethargy, or flu-like symptoms
  • Sleep disturbances
  • Sensory disturbances

Psychological symptoms may include:

  • Anxiety or agitation
  • Irritability
  • Mood changes

These symptoms typically emerge within the first week after dose reduction and are generally self-limiting 3. One case report documented orthostatic hypotension with sertraline withdrawal that required extended tapering 5.

Important Caveats

Tapering Pace Flexibility

The taper should be adjusted based on your response. If you experience significant withdrawal symptoms:

  • The pace should be slowed
  • Dose reductions should be smaller
  • The taper can be paused temporarily 2

If intolerable symptoms occur, your clinician may need to return to the previous dose and then taper more gradually 2.

Duration Expectations

Be realistic about timeline: Given your four-year duration of use, a complete taper may take several months. Research suggests agents with shorter half-lives like sertraline require gradual tapering 3, and recent evidence indicates higher-risk patients may require tapering over months 6.

Distinguishing Withdrawal from Relapse

Work with your clinician to differentiate withdrawal symptoms from depression relapse. Withdrawal symptoms typically:

  • Emerge within days of dose reduction
  • Are often physical in nature
  • Improve with dose stabilization

Depression relapse typically:

  • Develops more gradually over weeks
  • Involves core depressive symptoms
  • Does not improve with dose stabilization

Monitoring Plan

Request a structured follow-up schedule:

  • Initial visit: Baseline labs and taper plan
  • Week 2-4: First dose reduction and symptom assessment
  • Every 2-4 weeks thereafter: Ongoing monitoring during taper
  • Post-discontinuation: Follow-up 2-4 weeks after final dose to monitor for protracted withdrawal 6

What to Bring to the Appointment

  • Medication history: Exact dates of sertraline initiation and any prior dose changes
  • Symptom diary: Documentation of when your cold sensation began and its characteristics
  • Previous attempts: Any prior experiences with missed doses or medication changes
  • Current medications: Complete list including over-the-counter supplements 2

The key is advocating for a collaborative, gradual approach with close monitoring and flexibility to adjust the taper based on your individual response 2, 3, 6.

References

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

The effect of sertraline on routine blood chemistry values.

Clinical neuropharmacology, 2000

Research

Stopping antidepressants safely.

African journal of primary health care & family medicine, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.